BR0308211A - Cumarinas úteis como biomarcadores - Google Patents

Cumarinas úteis como biomarcadores

Info

Publication number
BR0308211A
BR0308211A BR0308211-3A BR0308211A BR0308211A BR 0308211 A BR0308211 A BR 0308211A BR 0308211 A BR0308211 A BR 0308211A BR 0308211 A BR0308211 A BR 0308211A
Authority
BR
Brazil
Prior art keywords
biomarkers
useful
coumarins
coumarins useful
formula
Prior art date
Application number
BR0308211-3A
Other languages
English (en)
Inventor
Yves Auberson
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9932424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308211(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0308211A publication Critical patent/BR0308211A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"CUMARINAS úTEIS COMO BIOMARCADORES". A invenção proporciona compostos de fórmula I em que R, R~ 1~, R~ 2~, R~ 3~ e R~ 4~ São como definidos na descrição, e a sua preparação. Os compostos de fórmula i são úteis como biomarcadores.
BR0308211-3A 2002-03-06 2003-03-05 Cumarinas úteis como biomarcadores BR0308211A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205281.9A GB0205281D0 (en) 2002-03-06 2002-03-06 Organic compounds
PCT/EP2003/002251 WO2003074519A1 (en) 2002-03-06 2003-03-05 Coumarines useful as biomarkers

Publications (1)

Publication Number Publication Date
BR0308211A true BR0308211A (pt) 2004-12-21

Family

ID=9932424

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308211-3A BR0308211A (pt) 2002-03-06 2003-03-05 Cumarinas úteis como biomarcadores

Country Status (24)

Country Link
US (1) US7569337B2 (pt)
EP (1) EP1483262B1 (pt)
JP (2) JP4247123B2 (pt)
KR (1) KR20040095257A (pt)
CN (1) CN1628114A (pt)
AR (1) AR038723A1 (pt)
AT (1) ATE378333T1 (pt)
AU (1) AU2003210418A1 (pt)
BR (1) BR0308211A (pt)
CA (1) CA2472298A1 (pt)
CO (1) CO5611123A2 (pt)
DE (1) DE60317476T2 (pt)
EC (1) ECSP045255A (pt)
ES (1) ES2294304T3 (pt)
GB (1) GB0205281D0 (pt)
MX (1) MXPA04008570A (pt)
NO (1) NO20044174L (pt)
PE (1) PE20030890A1 (pt)
PL (1) PL370916A1 (pt)
PT (1) PT1483262E (pt)
RU (1) RU2004129733A (pt)
TW (1) TW200400049A (pt)
WO (1) WO2003074519A1 (pt)
ZA (1) ZA200405175B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds
JP2007504283A (ja) * 2003-05-20 2007-03-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア β−アミロイド斑に作用物質を結合させる方法
JP2007084526A (ja) * 2004-11-26 2007-04-05 Nagasaki Univ アミロイド関連疾患診断用組成物
EP1815872A4 (en) * 2004-11-26 2011-06-15 Univ Nagasaki COMPOSITION FOR THE DIAGNOSIS OF AMYLOID ASSOCIATED DISEASE
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
RU2008150377A (ru) * 2006-05-19 2010-06-27 Нихон Меди-Физикс Ко., Лтд. (Jp) Новое соединение, обладающее сродством к амилоиду
TW200811175A (en) * 2006-06-21 2008-03-01 Nihon Mediphysics Co Ltd Novel compound with affinity with amyloid
AU2007261985B2 (en) * 2006-06-21 2012-04-19 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
EP2119458B9 (en) 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
EP2213672A4 (en) * 2007-10-24 2012-05-02 Nihon Mediphysics Co Ltd NEW CONNECTION WITH AFFINITY TO AMYLOID
KR20100089858A (ko) * 2007-10-30 2010-08-12 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법
KR20100101577A (ko) * 2007-10-30 2010-09-17 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법
JP6193881B2 (ja) * 2011-12-30 2017-09-06 ピーティーシー セラピューティクス, インコーポレイテッド 脊髄性筋萎縮症を治療するための化合物
EP2804852A2 (en) 2012-01-20 2014-11-26 Regents Of The University Of Minnesota Therapeutic compounds
CA2862084C (en) * 2012-01-26 2021-05-11 Ptc Therapeutics, Inc. 1h-isochromen-1-one derivatives and compositions thereof for treating spinal muscular atrophy
ES2697174T3 (es) 2012-02-10 2019-01-22 Ptc Therapeutics Inc Compuestos para tratar atrofia muscular espinal
KR102099997B1 (ko) * 2012-03-01 2020-04-13 피티씨 테라퓨틱스, 인크. 척수성 근위축증을 치료하기 위한 화합물
US9914722B2 (en) 2012-03-23 2018-03-13 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
CN104987328A (zh) * 2012-05-23 2015-10-21 复旦大学 7-氧、硫或氮杂取代香豆素及其衍生物和用途
WO2015105657A1 (en) 2013-12-19 2015-07-16 Ptc Therapeutics, Inc. Methods for modulating the amount of rna transcripts
US10668171B2 (en) 2015-05-30 2020-06-02 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
KR20220100719A (ko) 2015-12-10 2022-07-15 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 또는 개선을 위한 조성물
CA3043755A1 (en) 2016-11-28 2018-05-31 Ptc Therapeutics, Inc. Methods for modulating rna splicing
CN109476674B (zh) 2016-12-22 2021-12-10 伊鲁米纳剑桥有限公司 香豆素化合物及其作为荧光标记物的用途
CN108061725B (zh) * 2017-02-16 2020-04-21 昆明医科大学 1,8-萘啶基荧光分子探针在氯胺酮娱乐性滥用神经机制研究及成瘾程度诊断中的应用
AU2018282154B2 (en) 2017-06-05 2022-04-07 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
KR20200017476A (ko) 2017-06-14 2020-02-18 피티씨 테라퓨틱스, 인크. Rna 스플라이싱의 변경 방법
CA3067591A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
WO2019005993A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
AU2019243048A1 (en) 2018-03-27 2020-10-15 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
BR112020026534A2 (pt) 2018-06-27 2021-03-23 Ptc Therapeutics, Inc. Compostos de heteroarila para o tratamento da doença de huntington
IL279688B2 (en) 2018-06-27 2025-01-01 Ptc Therapeutics Inc Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
MY209343A (en) 2019-03-01 2025-07-03 Illumina Cambridge Ltd Exocyclic amine substituted coumarin compounds and uses as fluorescent labels
CN114245794B (zh) 2019-05-13 2024-09-13 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
CN112300201B (zh) * 2020-12-07 2021-11-23 南京林业大学 一种三聚茚基香豆素-咔咯-卟啉四元体系星型化合物的合成及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH390250A (de) * 1958-06-19 1965-07-30 Geigy Ag J R Verfahren zur Herstellung von fluoreszierenden Farbstoffen
DE2030507C3 (de) * 1970-06-20 1975-05-22 Bayer Ag, 5090 Leverkusen Oxazolyl-cumarine, deren Herstellung und Verwendung
JPS5529110B2 (pt) * 1972-12-25 1980-08-01
DE2410634A1 (de) * 1974-03-06 1975-09-18 Basf Ag 3-benzofurylcumarine
DE2411969A1 (de) * 1974-03-13 1975-09-25 Bayer Ag Farbstofflaser
DE2525986A1 (de) * 1975-06-11 1977-05-05 Bayer Ag Cumarinverbindungen
LU78311A1 (de) * 1977-10-13 1979-06-01 Ciba Geigy Ag Neue cumarinfarbstoffe,deren herstellung und verwendung
US4892922A (en) * 1987-11-30 1990-01-09 Eastman Kodak Company Polyester polymer containing the residue of a benzopyran colorant compound and shaped articles produced therefrom
JPH01169327A (ja) * 1987-12-25 1989-07-04 Mitsui Toatsu Chem Inc 紫外線検知用樹脂組成物
JP2999841B2 (ja) * 1991-04-03 2000-01-17 三井化学株式会社 発光スクリーン用樹脂組成物
EP0527433B1 (en) 1991-08-13 1997-01-08 Bayer Corporation Novel fluorescent label
JPH073179A (ja) * 1993-06-15 1995-01-06 Nippon Kayaku Co Ltd インクジェットプリント用インク組成物及びこれを用いる染色法
JP4028155B2 (ja) 2000-04-11 2007-12-26 日本カーバイド工業株式会社 蛍光性再帰反射シート
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
KR20040095257A (ko) 2004-11-12
NO20044174L (no) 2004-09-30
US7569337B2 (en) 2009-08-04
JP4247123B2 (ja) 2009-04-02
DE60317476T2 (de) 2008-05-21
CA2472298A1 (en) 2003-09-12
PL370916A1 (en) 2005-06-13
MXPA04008570A (es) 2004-12-06
ATE378333T1 (de) 2007-11-15
PE20030890A1 (es) 2003-12-05
ECSP045255A (es) 2004-09-28
GB0205281D0 (en) 2002-04-17
JP2005526749A (ja) 2005-09-08
AU2003210418A1 (en) 2003-09-16
CO5611123A2 (es) 2006-02-28
CN1628114A (zh) 2005-06-15
JP2009102322A (ja) 2009-05-14
TW200400049A (en) 2004-01-01
US20050169837A1 (en) 2005-08-04
DE60317476D1 (de) 2007-12-27
ES2294304T3 (es) 2008-04-01
RU2004129733A (ru) 2005-06-27
EP1483262B1 (en) 2007-11-14
WO2003074519A1 (en) 2003-09-12
ZA200405175B (en) 2005-06-21
PT1483262E (pt) 2008-02-11
EP1483262A1 (en) 2004-12-08
AR038723A1 (es) 2005-01-26

Similar Documents

Publication Publication Date Title
BR0208338A (pt) Derivados de piridina
BR0215405A (pt) Composições e processos de uso de collajolie
BR0111981A (pt) herbicidas de piridina substituìda
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
BR0214666A (pt) Derivados de acetileno tendo atividade antagonìstica de mglur5
NO20044174L (no) Kumariner som er nyttige som biomarkorer
FI20040391A0 (fi) Hakeosasten esikäsittely suurkuiduttamalla
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
BRPI0413973A (pt) compostos
DE60335716D1 (de) Beschleuniger-zusammensetzung
BR0209149A (pt) Ftalazinonas
DE60220915D1 (de) Interlabiale vorlage
BRPI0411001A (pt) produtos aril-heteroaromáticos, composições que os contêm e utilização
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR0317678A (pt) Piridodiazinas como fungicidas de planta
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
EP1568691A4 (en) ACCELERATOR FOR ERYTHROPOETIN PRODUCTION
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
BR0007922A (pt) Compostos calcilìticos
BR0115996A (pt) Sulfamidotienopirimidinas
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
BRPI0512310A (pt) compostos quìmicos
HRP20050611B1 (hr) Kombinacijski lijek
DE50107490D1 (de) Stoffgemisch enthaltend bisphenol a

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.